EUCR

NASDAQ

Eucrates Biomedical Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2020

News25/Ratings0

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Latest news

25 items

1081dSEC
SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
15-12G - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1093dSEC
SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
25-NSE - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1106dSEC
SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1108dNEWS
Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association. Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association. As part of that dissolution and liquidation, the Company will redeem all of the outstanding ordinary shares that were included in its initial public offering (the "Public Shares") at a per-share redemption price of approximately $10.00. A
1108dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1108dPR
Eucrates Biomedical Acquisition Corp. Announces Liquidation
NEW YORK, April 11, 2023 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (NASDAQ:EUCR) (the "Company") announced the following today: The Company anticipates that it will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association.Accordingly, the Company intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Memorandum and Articles of Association.As part of that dissolution and liquidation, the Company will redeem all of the outstandi
1116dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1121dSEC
SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1162dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1168d13D/G
SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1256dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1261d13D/G
SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.
SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1262dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1270dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1277dSEC
Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure
8-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1289dSEC
SEC Form DEF 14A filed by Eucrates Biomedical Acquisition Corp.
DEF 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1296dSEC
SEC Form PRER14A filed by Eucrates Biomedical Acquisition Corp.
PRER14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1303dSEC
SEC Form PRE 14A filed by Eucrates Biomedical Acquisition Corp.
PRE 14A - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1347dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1431dSEC
SEC Form 10-Q filed by Eucrates Biomedical Acquisition Corp.
10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1438dSEC
SEC Form NT 10-Q filed by Eucrates Biomedical Acquisition Corp.
NT 10-Q - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1476dSEC
SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1484dSEC
SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
NT 10-K - Eucrates Biomedical Acquisition Corp. (0001822929) (Filer)
1529d13D/G
SEC Form SC 13G filed by Eucrates Biomedical Acquisition Corp.
SC 13G - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)
1535d13D/G
SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
SC 13G/A - Eucrates Biomedical Acquisition Corp. (0001822929) (Subject)